HN1999000140A - Un metodo para la prevencion del inicio del asma. - Google Patents

Un metodo para la prevencion del inicio del asma.

Info

Publication number
HN1999000140A
HN1999000140A HN1999000140A HN1999000140A HN1999000140A HN 1999000140 A HN1999000140 A HN 1999000140A HN 1999000140 A HN1999000140 A HN 1999000140A HN 1999000140 A HN1999000140 A HN 1999000140A HN 1999000140 A HN1999000140 A HN 1999000140A
Authority
HN
Honduras
Prior art keywords
asthma
same
pharmaceutical salt
salt acceptable
prevention
Prior art date
Application number
HN1999000140A
Other languages
English (en)
Spanish (es)
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26792214&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HN1999000140(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of HN1999000140A publication Critical patent/HN1999000140A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
HN1999000140A 1998-08-18 1999-08-13 Un metodo para la prevencion del inicio del asma. HN1999000140A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9692998P 1998-08-18 1998-08-18
US9745598P 1998-08-21 1998-08-21

Publications (1)

Publication Number Publication Date
HN1999000140A true HN1999000140A (es) 2001-07-31

Family

ID=26792214

Family Applications (1)

Application Number Title Priority Date Filing Date
HN1999000140A HN1999000140A (es) 1998-08-18 1999-08-13 Un metodo para la prevencion del inicio del asma.

Country Status (16)

Country Link
EP (1) EP1109557B1 (enExample)
JP (1) JP3878416B2 (enExample)
AR (1) AR020167A1 (enExample)
AT (1) ATE228366T1 (enExample)
AU (1) AU749169B2 (enExample)
CA (1) CA2340920C (enExample)
DE (1) DE69904206T2 (enExample)
ES (1) ES2188232T3 (enExample)
HN (1) HN1999000140A (enExample)
MA (1) MA26676A1 (enExample)
MY (1) MY124089A (enExample)
PA (1) PA8480401A1 (enExample)
SA (1) SA99200492B1 (enExample)
TN (1) TNSN99158A1 (enExample)
TW (1) TW581675B (enExample)
WO (1) WO2000010544A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002221854A1 (en) * 2000-12-15 2002-06-24 U C B, S.A. Use of cetirizine or efletirizine for preventing urticaria
WO2005077371A1 (en) * 2004-02-12 2005-08-25 Ucb Farchim Sa Use of levocetirizine for the preparation of a drug
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof

Also Published As

Publication number Publication date
AR020167A1 (es) 2002-04-10
DE69904206T2 (de) 2003-07-17
PA8480401A1 (es) 2000-09-29
DE69904206D1 (de) 2003-01-09
AU5734699A (en) 2000-03-14
CA2340920C (en) 2007-10-16
WO2000010544A2 (en) 2000-03-02
AU749169B2 (en) 2002-06-20
ES2188232T3 (es) 2003-06-16
TW581675B (en) 2004-04-01
CA2340920A1 (en) 2000-03-02
MY124089A (en) 2006-06-30
EP1109557B1 (en) 2002-11-27
WO2000010544A3 (en) 2000-05-18
ATE228366T1 (de) 2002-12-15
JP3878416B2 (ja) 2007-02-07
MA26676A1 (fr) 2004-12-20
SA99200492B1 (ar) 2006-06-04
JP2002523362A (ja) 2002-07-30
EP1109557A2 (en) 2001-06-27
TNSN99158A1 (ar) 2005-11-10

Similar Documents

Publication Publication Date Title
BR0110486A (pt) Antranilamidas e sua aplicação como medicamento
BR9915553A (pt) Amidas de ácido antranìlico e seu emprego como medicamento
BR0307564A (pt) Derivados de nicotinamida úteis como inibidores de pde4
BR0210707A (pt) Formulações de olopatadina para administração tópica
ECSP034732A (es) Derivado de fenetanolamina para el tratamiento de enfermedades respiratorias
ES2165878T3 (es) Utilizacion del modafinil para el tratamiento de las apneas del sueño y trastornos de ventilacion de origen central.
ATE323479T1 (de) Zusammensetzung für die verhinderung der glattmuskelkrankheiten, die ascorbat, arginin und magnesium enthält
IS8175A (is) Píperasín afleiður og aðferðir við notkun þeirra
BR0306922A (pt) N-pirazinil-fenilsulfonamidas e seu uso no tratamento de doenças mediadas por quimocina
UY27658A1 (es) Derivados de nicotinamida y una sal de tiotropio en combinación para el tratamiento de enfermedades
DE3688038D1 (de) Verwendung von buspiron zur herstellung von pharmazeutischen zusammensetzungen zur linderung von krankhaften angst.
NO20074318L (no) Anvendelse av en fettsyresammensetning som inneholder DHA for fremstilling av et medisinsk produkt eller et naeringsmiddel for behandling av amyloidoserelaterte sykdommer
UY27656A1 (es) Derivados de nicotinamida y una sal de tiotropio en combinación para el tratamiento de enfermedades
ES2061727T3 (es) Sustancias fisiologicamente activas, un procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
AR012193A1 (es) Nuevas combinaciones terapeuticas
UY28317A1 (es) Compuestos útiles para el tratamiento de enfermedades
NO20050063L (no) 2-heteroaryl karboksamider
ES2091738T3 (es) Formulados farmaceuticos que contienen cefaclor.
CY1110644T1 (el) 5,6,7-τριυδροξυεπτανοϊκο οξυ και τα αναλογα για την θεραπεια οφθαλμικων ασθενειων που σχετιζονται με υπερεκφυτικες και αγγειογενεις αντιδρασεις
HUP0000386A1 (hu) Adamantánaminok és szerkezetileg hasonló vegyületek alkalmazása borna-betegséget okozó vírus leküzdésére, valamint kedélybetegségek és más, a borna-betegséget okozó vírusfertőzéssel kapcsolatos zavarok megelőzésére és kezelésére
BG101605A (bg) Ентерокинетични бензамиди
PA8488701A1 (es) Composiciones obtenidas a partir de mangifera indica l
CR7198A (es) Tableta que contiene cetirizina y pseudoefedrina
ATE428429T1 (de) Prostaglandine zur behandlung von lichtstrahlung erzeugten augenerkrankungen wie photoretinitis
SV2001000253A (es) Pirazolo (4,3-e) diazepinas sustituidas novedosas, composiciones farmaceuticas que las contienen, su uso como productos medicinales y procesos para prepararlas